Less expense ratio implies better returns over the long term

Expense Ratio

ETF has been able to closely match its benchmark's returns

Tracking Error

ETF has been generating better price return than bank FD

Return vs FD Rates

Good time to consider, as ETF is not in overbought zone

Entry Point

The Nifty Pharma index was trading 0.81 per cent at 21718.55.

Stock market update: Nifty Pharma index 0.81% in an upbeat market

Stocks including Reliance Industries, Hero MotoCorp, Grasim, Sobha, Honasa Consumer, Hindustan Zinc, Glenmark Pharma, Cyient and more will be in the spotlight on Monday, November 18.

Stocks in news: RIL, Hero Moto, Grasim, Delhivery, Honasa, Hindustan Zinc & Glenmark Pharma

The Nifty Pharma index was trading 0.49 per cent at 21644.70.

Stock market update: Nifty Pharma index 0.49% in a weak market

Equity benchmarks slide as Nifty50 falls below 23,400 levels amid global cues, tech and healthcare stock selling pressure.

Nifty sinks below 23,400 as tech, pharma stocks drag; Metals shine

Indian benchmark indices ended with declines on Thursday, marking their fifth consecutive fall. Today’s decline was led by FMCG and pharma stocks, which wiped out earlier morning gains. While the S&P BSE Sensex fell by 110 points, or 0.14%, to close at 77,580, the broader Nifty dropped by 26 points, or 0.11%, to end at 23,532, amid concerns over foreign outflows.Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities, said that the Nifty closed near its 200-day EMA, forming a gravestone doji-like pattern on the daily chart, signaling bearish sentiment. “This suggests a ‘sell on rise’ approach, as the index hovers in an oversold zone near a key EMA level. A bounce is likely, but it should be seen as an opportunity to sell. If Nifty breaks below the 200-day EMA, selling pressure could intensify. The index has support at 23,450, with resistance expected at 23,650, framing the short-term trading range,” De said.Here are 3 stock recommendations for Monday: Stock Ideas

Market Trading Guide: Bajaj Holdings among top 3 stock recommendations for Monday - Stock Ideas

Large and medium-sized companies see a lack of specific skills and talents as more of a concern than smaller ones, according to a report by GlobalData. The rapid pace of technological advancement has outstripped the ability of traditional training programs to keep up, creating a significant skills gap.

Global Pharma Sector Stares At Lack Of Talent, Specific Skills: Report

Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was announced as President-elect Donald Trumps nominee for Secretary of Health and Human Services.

Pfizer and Moderna stocks drop after RFK Jr.’s nomination for Health Secretary: impact on the Pharma Industry

RFK’s nomination as US health secretary by Trump sparks global interest, especially in pharmaceutical industry and health circles.

Trump’s choice for top health job, sends jitters through pharma and health circles

In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to respond to allegations about drug samples before such information is released to the public.

Pharma industry pushes for revamp in drug quality inspection to meet global standards

President-elect Donald Trump has selected Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services. The controversial pick has alarmed public health officials and sent ripples through the pharmaceutical industry, causing stock prices of major vaccine manufacturers to plummet.

Robert F. Kennedy Jr: Trump’s biggest anti-establishment bombshell?

Amidst October’s volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They invested in renewable energy companies due to increasing electricity demand and government initiatives. Anticipating a rise in government spending, cement stocks also attracted investments. However, some managers, wary of further market corrections, sought refuge in defensive pharmaceutical stocks.

MFs buy renewables, cement and pharma in October

The ETF tracks Nifty Pharma Index which is designed to reflect the behavior and performance of the pharmaceutical sector in India.